Literature DB >> 18612180

Prognosis of patients with papillary carcinoma showing anaplastic transformation in regional lymph nodes that were curatively resected.

Yasuhiro Ito1, Takuya Higashiyama, Mitsuyoshi Hirokawa, Mitsuhiro Fukushima, Hiroyuki Inoue, Tomonori Yabuta, Chisato Tomoda, Takashi Uruno, Minoru Kihara, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Akira Miyauchi.   

Abstract

Anaplastic carcinoma arises from differentiated carcinoma and generally shows a dire prognosis. Anaplastic transformation may occur not only in primary tumors but also in metastatic lymph nodes. We encountered 5 cases of papillary carcinoma showing anaplastic transformation in lymph nodes that were curatively resected. Patient ages ranged from 67 to 85 years. Two of these patients showed anaplastic transformation at the initial surgery and the remaining 3 showed anaplastic transformation after repeated recurrence to the lymph nodes. After resection of anaplastic lesions of the nodes, 2 patients underwent radiation therapy, whereas the remaining 3 did not receive any adjuvant therapy. One patient died of rapid growth of lung metastasis 5 months after the resection. One patient died of carcinoma 63 months after surgery. Two patients have survived to date, 6 and 85 months after resection, respectively. The remaining one patient died of heart failure 11 months after surgery. It is therefore suggested that long-term survival can be expected for patients with differentiated carcinoma showing anaplastic transformation in the lymph node if the lesions can be curatively resected.

Entities:  

Mesh:

Year:  2008        PMID: 18612180     DOI: 10.1507/endocrj.k08e-148

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

Review 1.  Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.

Authors:  R C Smallridge; J A Copland
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-24       Impact factor: 4.126

2.  Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.

Authors:  Haruhiko Yamazaki; Hiroyuki Iwasaki; Nobuyasu Suganuma; Soji Toda; Katsuhiko Masudo; Hirotaka Nakayama; Yasushi Rino; Munetaka Masuda
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-10-01

3.  Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.

Authors:  Toru Odate; Naoki Oishi; Masataka Kawai; Ippei Tahara; Kunio Mochizuki; Junko Akaishi; Koichi Ito; Ryohei Katoh; Tetsuo Kondo
Journal:  Endocr Pathol       Date:  2021-03-24       Impact factor: 3.943

4.  Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma.

Authors:  Nikola Besic; Barbara Gazic
Journal:  Radiol Oncol       Date:  2020-05-02       Impact factor: 2.991

5.  Rapid disease progression after discontinuation of lenvatinib in thyroid cancer.

Authors:  Haruhiko Yamazaki; Kiminori Sugino; Kenichi Matsuzu; Chie Masaki; Junko Akaishi; Kiyomi Hames; Chisato Tomoda; Akifumi Suzuki; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Munetaka Masuda; Koichi Ito
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.